THURSDAY, DECEMBER 8, 2016

Two suspected measles cases in Bermuda

According to a recent report from the Department of Health and the Epidemiology and Surveillance Unit (ESU), health professionals are investigating two measles cases in Bermuda. Read More »

Meningitis Angels encourage stronger Meningitis B vaccinations

At a recent hearing held by the Center for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices (ACIP), the Meningitis Angels testified to request stronger Meningitis B vaccinations. ACIP is currently seeking vaccines to fight the specific strain that causes the majority of meningococcal meningitis cases within the United States. Read More »

Delaware reports three more flu deaths

Three more flu-related deaths have been announced in Delaware, amounting to a total of 26 flu deaths in Delaware for this flu season. According to the recent announcement from the Division of Public Health (DPH), there have 2,196 flu cases confirmed by laboratories this flu season. Read More »

GlaxoSmithKline undergoing board changes

According to a recent announcement from GlaxoSmithKline (GSK), the company is undergoing several changes to its Board, including the fact that Sir Philip Hampton will take the place of Sir Christopher Gent as the Chairman of the GSK Board. Sir Philip originally joined the GSK Board on January 1, 2015. Read More »

Australian virus may be key to Ebola vaccine

A group of scientists recently used Kunjin, an Australian virus, to create an experimental Ebola vaccine. Read More »

GSK finishes transaction with Novartis

GlaxoSmithKline plc (GSK) completed a three-part transaction agreement with Novartis on Monday. Read More »

Pfizer gains EU approval for pneumococcal vaccine

The European Commission recently granted an expanded indication for Pfizer, Inc.'s Prevenar 13. Read More »

MHRA aids new approach to create malaria vaccine

The Medicines and Healthcare products Regulatory Agency (MHRA) and researchers from the University of Oxford’s Jenner Institute recently collaborated to develop a new method of creating malaria vaccines. This fourth case study will help create a viral vector, which researchers use to carry genetic material that will prevent or treat an individual disease. MHRA facilitated the project through introductions between researchers at Jenner Institute and various agency teams, such as goods manufactu Read More »

ResolutionMD software gains certification in Japan

Calgary Scientific Inc., a company that develops innovative technology for the medical industry, recently announced that its medical imaging software called ResolutionMD® has received Class II certification. The imaging software, which can be used on the web and on mobile devices, helps with the diagnosis process. Read More »

BD purchases CRISI Medical Systems

Becton, Dickinson and Company (BD), a leading technology company that innovates for the medical industry around the world, recently acquired CRISI Medical Systems, a technology company that improves IV injectable medications. The acquisition assists BD’s goal of remedying preventable errors in medications and deliveries. The two companies previously agreed to a partnership in 2013. Read More »

Chen named CASI's chief medical officer

CASI Pharmaceuticals, Inc., a biopharmaceutical company specializing in developing and selling novel therapies, recently appointed Rong Chen MD, PhD as the company’s new Chief Medical Officer. Dr. Chen has more than 20 years of experience in pharmaceutical regulatory affairs and clinical development. Dr. Chen attended Shandong Medical University in China for his medical degree. Read More »

Study shows adults contract flu twice every 10 years

Imperial College London study showed that adults older than 30 contract the flu only twice every decade. Read More »

Study reveals how malaria parasites quickly grow

A team at the University of South Florida College of Public Health and the University of Georgia recently discovered why malaria and similar parasites spread so quickly inside animals and humans. Malaria, which is drug-resistant, has become an increasingly serious public health issue. Read More »

FDA launches first drug shortages app

App will provide faster access to updated drug information. Read More »

Researchers search for next influenza strain

Researchers at Kansas State University are currently monitoring for the next strain of the influenza virus. Read More »

Promising new bird flu compound developed

Researchers have developed a new bird flu compound that shows promise, as it has already proven 100% effective in preventing lab models from contracting the bird flu. H5N1, also known as the bird flu, killed millions of ducks and chickens in 2003. Read More »

Nancy Wysenski joins Inovio Pharmaceutical board

Nancy Wysenski recently joined the board of directors of Inovio Pharmaceuticals Read More »

Polio threatens to spread in conflicted countries

Pakistan is latest country to report outbreak of devastating disease Read More »

Hexyon gains European Commission grant for 2+1 immunization schedule

The European Commission recently gave Sanofi Pasteur MSD permission for a new vaccination schedule of 2+1 doses for Hexyon®, a novel 6-in-1 pediatric DTaP-IPC-HB-Hib vaccine. The decision to approve the new 2+1 schedule calls for 2 doses and then 1 booster vaccine. Read More »

Ebola vaccine trial to start in Guinea

Several health organizations (the World Health Organization, the Health Ministry of Guinea, Medecins Sans Frontieres, the Norwegian Institute of Public Health, and the Epicentre) will soon begin a Phase III trial of the VSV-EBOV Ebola vaccine. The trial, which will begin on March 7, 2015, will determine the safety and effectiveness of the vaccine in preventing Ebola. Read More »